Listening to what matters most: Consumer endorsed patient reported outcome measures (PROMs) for use in multiple myeloma clinical trials: a descriptive exploratory study

This study aimed to identify consumer-endorsed patient reported outcome measures (PROMs) for use in clinical trials with Multiple Myeloma patients. Twenty-six individuals reviewed 10 commonly used PROMs for acceptability, appropriateness, and practicability. The MyPOS, the Brief Fatigue Inventory, and COST-FACIT were endorsed and are proposed for use in future trials where quality of life is an outcome of interest.

Source: Clinical Lymphoma, Myeloma and Leukemia - March 31, 2023 Category: Hematology Authors: Hayley Beer, Holly Chung, Simon J Harrison, Hang Quach, Meinir Krishnasamy Source Type: research